Results 111 to 120 of about 27,228 (223)

Lipemia Retinalis with Proliferative Diabetic Retinopathy: A Case Report. [PDF]

Korean J Ophthalmol
Park SC, Park HS, Jung WH, Park JH, Han JW, Park TK.   +5 more
europepmc   +1 more source

Emerging Role of Ferroptosis in Diabetes and Associated Complications: When Metabolic Dysregulation Meets Cell Death

Cell Proliferation, Volume 59, Issue 5, May 2026.
This study identifies ferroptosis as a key driver of diabetes and its complications via iron metabolism and lipid peroxidation, elucidates organelle interactions underlying cell vulnerability, and provides insights for targeted therapies against metabolic disorders.
Zheng Wang, Ying Zhang, Yue Xu, Mengyuan Yang, Yuan Wei, Yuan Li, Tongyue Yang, Xu Wang, Chaona Yang, Qi Feng, Guolan Xing   +10 more
wiley   +1 more source

Clinical efficacy of Conbercept combined with pars plana vitrectomy for proliferative diabetic retinopathy. [PDF]

Am J Transl Res
Chen Y, Wang M, Gao J.
europepmc   +1 more source

Cost‐utility of once‐weekly insulin icodec versus once‐daily basal insulins for type 2 diabetes in China

Diabetes, Obesity and Metabolism, Volume 28, Issue 5, Page 3872-3882, May 2026.
Abstract Objective To comprehensively assess the cost‐utility of icodec, the first once‐weekly basal insulin, at 700 and 1050 U formulations compared with once‐daily basal insulin analogues in Chinese adults with type 2 diabetes within reimbursement context.
Xichen Tong, Chang Xing, Lei Zhang, Luying Zhang   +3 more
wiley   +1 more source

Assessment of pan-immune-inflammation value as a novel marker of proliferative diabetic retinopathy stage. [PDF]

Int J Ophthalmol
Candan O, Orman G, Ünlü N, Uney G.
europepmc   +1 more source

Cost‐effectiveness analysis of Dexcom ONE+ real‐time continuous glucose monitoring versus self‐monitoring of blood glucose in people with type 2 diabetes in Aotearoa New Zealand

Diabetes, Obesity and Metabolism, Volume 28, Issue 5, Page 4055-4065, May 2026.
Abstract Aims Real‐time continuous glucose monitors (rt‐CGM) have been found effective and economical for the treatment of diabetes in many countries. The objective of this study was to provide a cost‐effectiveness analysis of rt‐CGM versus self‐monitoring of blood glucose (SMBG) from the perspective of a healthcare payer in New Zealand.
Ryan G. Paul, Jessica Y. Matuoka, Hamza A. Alshannaq, Richard F. Pollock, Gregory J. Norman   +4 more
wiley   +1 more source

Dysregulated hyaluronan metabolism drives inflammation and angiogenesis in proliferative diabetic retinopathy. [PDF]

Front Immunol
Abu El-Asrar AM, Nawaz MI, Ahmad A, Siddiquei M, Allegaert E, Gikandi PW, De Hertogh G, Opdenakker G.   +7 more
europepmc   +1 more source

Impact of specialised endocrinology care on metabolic control and healthcare utilisation outcomes after kidney transplantation in patients with diabetes: A 12‐month observational cohort study

Diabetes, Obesity and Metabolism, Volume 28, Issue 5, Page 4082-4090, May 2026.
Abstract Aims To evaluate whether an endocrinology‐integrated transplant clinic and differing healthcare delivery models are associated with metabolic outcomes during the first year after kidney transplantation in recipients with pre‐existing diabetes.
Joaquin Lado‐Abeal, Francisco Gude, Maria Jose Ginzo‐Villamayor, Khalid Al‐Zubaidi, Jacqueline C. Stocking, Gemma Rodriguez‐Carnero, Aili Guo, Prasanth Surampudi, Caroline Lenaerts, Vedesh K. Babu, Deborah Plante, Yihung Huang, Antia Fernandez‐Pombo   +12 more
wiley   +1 more source

Monochromatic Phacoemulsification: An Approach for Eyes With Impaired Red Reflex Secondary to Proliferative Diabetic Retinopathy. [PDF]

Cureus
Ramírez-Estudillo JA, Bayram-Suverza M, Ramírez-Galicia X, Hernandez Ruiz G.   +3 more
europepmc   +1 more source

Highly Uncontrolled Cardiovascular Risk in Emerging Adults With Paediatric‐Onset Type 1 Diabetes—A Cross‐Sectional Analysis From the Diabetes Prospective Follow‐Up Registry DPV

Diabetes, Obesity and Metabolism, Volume 28, Issue 5, Page 4194-4204, May 2026.
ABSTRACT Aims Cardiovascular disease (CVD) is a major contributor to premature morbidity and mortality in individuals with type 1 diabetes (T1DM). Glycaemic control often deteriorates during the transition from paediatric to adult care, and thus we assessed the prevalence and pharmacological management of overt and actionable modifiable cardiovascular ...
Alena Welters, Christina Reinauer, Karl Otfried Schwab, Claudia Boettcher, Melanie Hess, Heike Bartelt, Axel Dost, Joachim Rosenbauer, Angela Galler, Reinhard W. Holl   +9 more
wiley   +1 more source